(Q31130703)

29 June 2017

title

Epidemiology and costs of herpes zoster: background data to estimate the impact of vaccination (English)

1 reference

29 June 2017

1 reference

1 reference

Maria Michela Gianino

object named as

Maria Michela Gianino

2

0 references

Marco Massari

4

object named as

Marco Massari

1 reference

29 June 2017

Gianpaolo Scalia Tomba

6

object named as

Gianpaolo Scalia Tomba

1 reference

29 June 2017

Valeria Di Legami

1

1 reference

29 June 2017

Marta Ciofi degli Atti

3

1 reference

29 June 2017

Alessandro Migliardi

5

1 reference

29 June 2017

Carla Zotti

7

1 reference

29 June 2017

Zoster Study Group

8

1 reference

29 June 2017

language of work or name

English

0 references

publication date

15 August 2007

1 reference

29 June 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

29 June 2017

volume

25

1 reference

29 June 2017

issue

43

1 reference

29 June 2017

page(s)

7598-7604

1 reference

Population-based study of herpes zoster and its sequelae

29 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.049

Epidemiology of varicella zoster virus infection in Canada and the United Kingdom

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.049

What does epidemiology tell us about risk factors for herpes zoster?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.049

Current management of herpes zoster: the European view.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.049

Herpes zoster and its complications in Italy: an observational survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.049

Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.049

Cost-benefit analysis of universal varicella vaccination in the U.S. taking into account the closely related herpes-zoster epidemiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.049

The epidemiology of herpes zoster and potential cost-effectiveness of vaccination in England and Wales

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.049

Varicella vaccination: impact of vaccine efficacy on the epidemiology of VZV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.049

The incidence of shingles and its implications for vaccination policy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.049

Incidence of Herpes Zoster, Before and After Varicella‐Vaccination–Associated Decreases in the Incidence of Varicella, 1992–2002

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.049

The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998-2003

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.049

Varicella susceptibility and incidence of herpes zoster among children and adolescents in a community under active surveillance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.049

Effects of varicella vaccination on herpes zoster incidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.049

The burden of Herpes Zoster: a prospective population based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.049

The incidence of herpes zoster

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.049

[Epidemiology of varicella zoster infection. Results of a prospective study in the Ansbach area]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.049

Characteristics of patients with herpes zoster on presentation to practitioners in France

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.049

Epidemiology of Varicella-Zoster Virus in England and Wales

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.049

Do herpes zoster patients receive antivirals? A Dutch national survey in general practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.049

Epidemiology of primary varicella and herpes zoster hospitalizations: the pre-varicella vaccine era.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.049

Case-control study of the effect of mechanical trauma on the risk of herpes zoster

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.049

Herpes zoster guideline of the German Dermatology Society (DDG).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.049

10.1016/J.VACCINE.2007.07.049

7 January 2021

Identifiers

DOI

1 reference

release_4h7vuneprjcb7kaqawbh2ujhnq

29 June 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4h7vuneprjcb7kaqawbh2ujhnq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference